Vereo® Automated Actuators
Proveris’s patented Vereo® automated actuators reliably replicate hand use of nasal and oral spray pumps and metered dose inhalers. Vereo actuator MicroDrive™ technology provides pinpoint accuracy fo...
Proveris accelerates the success of nasal and aerosol drug developers by providing a proven testing protocol, patented instrumentation and methodology, and a software platform that unifies all test methods, data, and analysis. Proveris provides:
Proveris’s patented Vereo® automated actuators reliably replicate hand use of nasal and oral spray pumps and metered dose inhalers. Vereo actuator MicroDrive™ technology provides pinpoint accuracy fo...
Proveris’s SprayVIEW® instrumentation established the standard now recommended by the FDA for automated spray pattern and plume geometry measurement testing of spray and aerosol delivered drugs. The ...
Proveris accelerates the success of nasal and aerosol drug developers by providing a proven testing protocol, patented instrumentation and methodology, and a software platform that unifies all test methods, data, and analysis. Proveris provides:
Leading pharmaceutical companies around the world turn to Proveris for the expertise required to tackle the challenges of developing safe, effective, and innovative spray therapies.
Proveris’s proven track record of dedication to customer success has made it the company pharmaceutical developers and the FDA rely on for software, instrumentation, protocols, and support for test regimes that bring next-generation spray-delivered drugs to market faster and more efficiently than ever before.
Proveris Scientific Corporation 290 Donald Lynch Boulevard, Suite 100 Marlborough, MA 01752 U.S.A.
Website link